"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDN
Enrolling by invitation
Conditions studied: Hypertension
In brief
This study is an observational one, collecting real-world data generated in routine clinical treatment. The Netrod-RDN renal artery radiofrequency ablation system (including the renal artery radiofrequency ablation device and the disposable mesh renal artery radiofrequency ablation catheter) produced and provided by Shanghai Meiliweiye Medical Technology Co., Ltd. was used to perform percutaneous renal denervation (RDN) on patients with refractory hypertension and drug intolerance in the real world. Refractory hypertension is defined as patients whose blood pressure remains uncontrolled despite taking three or more antihypertensive drugs (including one diuretic) for more than three months; drug intolerance refers to patients who have contraindications to drugs or cannot tolerate drug administration due to adverse drug reactions.
Key facts
- Study ID
- NCT07273877
- Run by
- Shanghai Golden Leaf MedTec Co. Ltd
- People needed
- 1000
- Starts
- 2025-08-07
- Expected to finish
- 2030-12-30
- Last updated by the study team
- 2026-04-20
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- (1) Patients who have already used or are planning to use the Netrod-RDN renal artery radiofrequency ablation system for RDN surgery;
- (2) Patients understand the requirements and treatment of this clinical study, agree to follow the requirements of this clinical study for follow-up, and sign the informed consent form before undergoing any special examinations and operations related to the study.
You may not qualify if…
- Patients with contraindications for RDN surgery and/or those who the researchers consider unsuitable for RDN or who do not wish to participate in this study.
Where it is running
- Capital Medical University Beijing Anzhen Hospital — Beijing, Beijing Municipality, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.